down arrow

Themis Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
124.45
8.65 (7.47%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.71 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

119.45125.00

52 Week

115.05313.65
Valuation
Technical
Day's Volume

CASH

1.71 lacs (30.72%) Volume

Shareholding (Dec 2024)

FII

0.10%

Held by 15 FIIs

DII

0.01%

Held by 0 DIIs

Promoter

67.15%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Negative results in Dec 24

  • PAT(Q) At Rs 0.52 cr has Fallen at -96.1% (vs previous 4Q average)
  • NET SALES(Q) At Rs 93.81 cr has Fallen at -10.7% (vs previous 4Q average)
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 17.60 cr
2

Stock is technically in a Bearish range

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,145 Cr (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.43%

stock-summary
Debt Equity

0.16

stock-summary
Return on Equity

12.86%

stock-summary
Price to Book

2.59

Revenue and Profits (1 Year):
Net Sales:
94 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.43%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-53.77%
0%
-53.77%
1 Year
-42.83%
0.23%
-42.6%
2 Years
-4.05%
3.57%
-0.48%
3 Years
32.59%
13.07%
45.66%
4 Years
288.66%
30.79%
319.45%
5 Years
356.53%
53.57%
410.1%

Latest dividend: 0.5 per share ex-dividend date: Jul-12-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.69%
EBIT Growth (5y)
47.04%
EBIT to Interest (avg)
5.66
Debt to EBITDA (avg)
1.48
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.85
Tax Ratio
22.52%
Dividend Payout Ratio
10.57%
Pledged Shares
2.43%
Institutional Holding
0.11%
ROCE (avg)
15.22%
ROE (avg)
17.74%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
2.59
EV to EBIT
21.04
EV to EBITDA
17.61
EV to Capital Employed
2.37
EV to Sales
2.62
PEG Ratio
12.55
Dividend Yield
0.43%
ROCE (Latest)
11.06%
ROE (Latest)
12.86%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

2.427

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 15 FIIs (0.1%)

Promoter with highest holding

Vividhmargi Investments Pvt (15.78%)

Highest Public shareholder

Anuj Anantrai Sheth (4.67%)

Individual Investors Holdings

24.24%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -19.83% vs -4.86% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -96.36% vs -42.10% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "93.81",
          "val2": "117.01",
          "chgp": "-19.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.53",
          "val2": "17.13",
          "chgp": "-50.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.79",
          "val2": "2.44",
          "chgp": "14.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.52",
          "val2": "14.29",
          "chgp": "-96.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.09%",
          "val2": "14.64%",
          "chgp": "-5.55%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 19.15% vs 8.62% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 32.09% vs -16.12% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "240.00",
          "val2": "201.43",
          "chgp": "19.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.30",
          "val2": "34.15",
          "chgp": "35.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.80",
          "val2": "4.53",
          "chgp": "5.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "38.98",
          "val2": "29.51",
          "chgp": "32.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.29%",
          "val2": "16.95%",
          "chgp": "2.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 17.56% vs 3.54% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.10% vs -23.94% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "333.81",
          "val2": "283.94",
          "chgp": "17.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.83",
          "val2": "42.21",
          "chgp": "29.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.59",
          "val2": "7.21",
          "chgp": "5.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "39.50",
          "val2": "36.88",
          "chgp": "7.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.43%",
          "val2": "14.87%",
          "chgp": "1.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 7.74% vs -10.21% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -23.51% vs -21.93% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "381.76",
          "val2": "354.32",
          "chgp": "7.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "51.51",
          "val2": "67.44",
          "chgp": "-23.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.38",
          "val2": "9.56",
          "chgp": "-1.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "43.52",
          "val2": "56.90",
          "chgp": "-23.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.49%",
          "val2": "19.03%",
          "chgp": "-5.54%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
93.81
117.01
-19.83%
Operating Profit (PBDIT) excl Other Income
8.53
17.13
-50.20%
Interest
2.79
2.44
14.34%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.52
14.29
-96.36%
Operating Profit Margin (Excl OI)
9.09%
14.64%
-5.55%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -19.83% vs -4.86% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -96.36% vs -42.10% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
240.00
201.43
19.15%
Operating Profit (PBDIT) excl Other Income
46.30
34.15
35.58%
Interest
4.80
4.53
5.96%
Exceptional Items
0.00
0.00
Consolidate Net Profit
38.98
29.51
32.09%
Operating Profit Margin (Excl OI)
19.29%
16.95%
2.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 19.15% vs 8.62% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 32.09% vs -16.12% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
333.81
283.94
17.56%
Operating Profit (PBDIT) excl Other Income
54.83
42.21
29.90%
Interest
7.59
7.21
5.27%
Exceptional Items
0.00
0.00
Consolidate Net Profit
39.50
36.88
7.10%
Operating Profit Margin (Excl OI)
16.43%
14.87%
1.56%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 17.56% vs 3.54% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 7.10% vs -23.94% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
381.76
354.32
7.74%
Operating Profit (PBDIT) excl Other Income
51.51
67.44
-23.62%
Interest
9.38
9.56
-1.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
43.52
56.90
-23.51%
Operating Profit Margin (Excl OI)
13.49%
19.03%
-5.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 7.74% vs -10.21% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -23.51% vs -21.93% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Themis Medicare Ltd stock-summary
stock-summary
Themis Medicare Ltd
Small Cap
Pharmaceuticals & Drugs
Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
Company Coordinates stock-summary
Company Details
Plot No 69 A GIDC Indl Estate, Vapi Valsad Gujarat : 396195
stock-summary
Tel: 91-260-2421675
stock-summary
http://www.themismedicare.com
stock-summary
themis@themismedicare.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."